Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Sales | 665,000 | 595,000 | 683,165 | 705,263 | 625,360 |
| Gross Profit | 665,000 | 595,000 | 683,165 | 705,263 | 625,360 |
| Operating Income | 665,000 | 595,000 | 683,165 | 705,263 | 625,360 |
| Pre-tax Income | 665,000 | 595,000 | 683,165 | 705,263 | 625,360 |
| Net Income Continuous | 107,000 | 83,000 | 94,019 | 96,328 | 83,708 |
| Net Income | $107,000 | $83,000 | $94,019 | $96,328 | $83,708 |
| EPS Basic Total Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Basic Continuous Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted Total Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted Continuous Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EBITDA(a) | $665,000 | $595,000 | $683,165 | $705,263 | $625,360 |